Unknown

Dataset Information

IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells.


ABSTRACT: Interleukin (IL)-24, a novel tumor suppressor/cytokine exhibits antitumor activity against a broad-spectrum of human cancer cells. In a recent study, we showed that IL-24 inhibited AKT in lung cancer cells. However, the molecular mechanism of AKT inhibition by IL-24 remains elusive.The high mobility group (HMG) A1 a member of the non-histone chromosomal proteins and commonly referred to as architectural transcription factor, regulates transcription of various genes involved in cell growth and survival. Overexpression of HMGA1 has been shown to be associated with tumor progression and metastasis in several cancers, including human lung cancer. A recent study demonstrated that HMGA1 activates AKT function by reducing the activity of the protein phosphatase, phosphatase 2A subunit B (PPP2R2A)

SUBMITTER: Panneerselvam J 

PROVIDER: S-EPMC5342550 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature